Elevation of CD5L was documented in patients with systemic lupus erythematosus, ARDS, chronic kidney disease, cardiovascular events, liver fibrosis, etc. [46,47,48,49,50]. This evidence concerns the gene CD5L and Hepatic fibrosis.